Point72 (Difc) LTD Acumen Pharmaceuticals, Inc. Transaction History
Point72 (Difc) LTD
- $2.81 Trillion
- Q2 2024
A detailed history of Point72 (Difc) LTD transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 4,018 shares of ABOS stock, worth $11,692. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,018Holding current value
$11,692% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABOS
# of Institutions
84Shares Held
41.8MCall Options Held
239KPut Options Held
65.9K-
Ra Capital Management, L.P. Boston, MA14.9MShares$43.5 Million0.54% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$9.94 Million4.16% of portfolio
-
Franklin Resources Inc San Mateo, CA3.37MShares$9.8 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$6.69 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$6.28 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $118M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...